These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7379440)

  • 1. Interaction between oral propranolol and hydralazine.
    McLean AJ; Skews H; Bobik A; Dudley FJ
    Clin Pharmacol Ther; 1980 Jun; 27(6):726-32. PubMed ID: 7379440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between oral hydralazine and propranolol. I. Changes in absorption, presystemic clearance and splanchnic blood flow.
    Heinzow B; Corbett H; Constantinides S; Bourne R; McLean AJ
    J Pharmacol Exp Ther; 1984 May; 229(2):509-14. PubMed ID: 6716273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extraction.
    Corbett H; Cahill CM; Heinzow B; Harrison PM; Byrne AJ; McLean AJ
    J Pharmacol Exp Ther; 1986 Nov; 239(2):517-21. PubMed ID: 3772806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions.
    Byrne AJ; McNeil JJ; Harrison PM; Louis W; Tonkin AM; McLean AJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):45S-50S. PubMed ID: 6743474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism by which hydralazine increases propranolol bioavailability.
    Schneck DW; Vary JE
    Clin Pharmacol Ther; 1984 Apr; 35(4):447-53. PubMed ID: 6705442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hydralazine on the pharmacokinetics of orally administered d-propranolol and lidocaine in conscious dogs.
    Heinzow BG; Somogyi A; McLean AJ
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):5-14. PubMed ID: 3592861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of propranolol.
    Routledge PA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hydralazine on the elimination of antipyrine in the rat.
    Svensson CK; Knowlton PW; Ware JA
    Pharm Res; 1987 Dec; 4(6):515-8. PubMed ID: 3508566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of hydralazine and alpha- or beta-adrenergic blockers: the role of plasma renin activity.
    Gutkin M; Das B; Chin BK; Mezey K; Modlinger RS
    J Clin Pharmacol; 1977; 17(8-9):509-18. PubMed ID: 893737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine.
    Schäfer-Korting M; Mutschler E
    Eur J Clin Pharmacol; 1982; 21(4):315-23. PubMed ID: 7056277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol.
    Shand DG
    Dis Mon; 1974 Oct; ():1-31. PubMed ID: 4606956
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-dependent disposition of oral propranolol in normal subjects.
    Mackichan JJ; Pyszczynski DR; Jusko WJ
    Biopharm Drug Dispos; 1980; 1(4):159-66. PubMed ID: 7448344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.
    Nicholls DP; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1983 Jan; 15(1):21-9. PubMed ID: 6849740
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of food intake on presystemic clearance of drugs.
    Melander A; McLean A
    Clin Pharmacokinet; 1983; 8(4):286-96. PubMed ID: 6352137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol given twice daily in hypertension.
    Berglund G; Andersson O; Hansson L; Olander R
    Acta Med Scand; 1973 Dec; 194(6):513-5. PubMed ID: 4204165
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-dependent presystemic elimination of propranolol due to hepatic first-pass metabolism in rats.
    Iwamoto K; Watanabe J
    J Pharm Pharmacol; 1985 Nov; 37(11):826-8. PubMed ID: 2867168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct measurement of propranolol bioavailability during accumulation to steady-state.
    Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG
    Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.